These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 30219356)

  • 21. [Immunologic phenotype of lymphocytes in chronic B-cell lymphocytic leukemia. II. Studies of immunologic phenotype of peripheral blood and lymph node lymphocytes in patients with chronic lymphocytic leukemia or leukemic forms of lymphoplasmacytoid lymphoma].
    Rupniewska ZM; Rozynkowa D; Antosz H; Kowal M; Wach M; Roliński J
    Acta Haematol Pol; 1992; 23(1):29-41. PubMed ID: 1615749
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CD40 triggering enhances fludarabine-induced apoptosis of chronic lymphocytic leukemia B-cells through autocrine release of tumor necrosis factor-alpha and interferon-gama and tumor necrosis factor receptor-I-II upregulation.
    de Totero D; Tazzari PL; Capaia M; Montera MP; Clavio M; Balleari E; Foa R; Gobbi M
    Haematologica; 2003 Feb; 88(2):148-58. PubMed ID: 12604404
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Cytoplasmic immunoglobulins in chronic B-lymphoid leukemia].
    Filippi JF; Nicolino-Brunet C; Tubiana N; Carcassonne Y; Sampol J
    Pathol Biol (Paris); 1991 Jan; 39(1):47-9. PubMed ID: 2011410
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Selective toxicity of persian gulf sea cucumber holothuria parva on human chronic lymphocytic leukemia b lymphocytes by direct mitochondrial targeting.
    Salimi A; Motallebi A; Ayatollahi M; Seydi E; Mohseni AR; Nazemi M; Pourahmad J
    Environ Toxicol; 2017 Apr; 32(4):1158-1169. PubMed ID: 27404045
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chronic lymphocytic leukemia developing in a patient with chronic myeloid leukemia: evidence of distinct lineage-associated genomic events.
    Gargallo P; Cacchione R; Chena C; Dupont J; Garay G; Riveros D; Larripa I; Slavutsky I
    Cancer Genet Cytogenet; 2005 Aug; 161(1):74-7. PubMed ID: 16080961
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Surface immunoglobulin on B lymphocytes as a potential target for specific peptide ligands in chronic lymphocytic leukaemia.
    Buhl L; Szecsi PB; Gisselø GG; Schafer-Nielsen C
    Br J Haematol; 2002 Mar; 116(3):549-54. PubMed ID: 11849210
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Role of decreased production of interleukin-10 and interferon-gamma in spontaneous apoptosis of B-chronic lymphocytic leukemia lymphocytes in vitro.
    Djurdjevic P; Zelen I; Ristic P; Baskic D; Popovic S; Arsenijevic N
    Arch Med Res; 2009 Jul; 40(5):357-63. PubMed ID: 19766898
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Z-138: a new mature B-cell acute lymphoblastic leukemia cell line from a patient with transformed chronic lymphocytic leukemia.
    Estrov Z; Talpaz M; Ku S; Harris D; Van Q; Beran M; Hirsch-Ginsberg C; Huh Y; Yee G; Kurzrock R
    Leuk Res; 1998 Apr; 22(4):341-53. PubMed ID: 9669839
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differences in IgE isotype switching induced by anti-CD40 monoclonal antibody and cytokines among subtypes of chronic B lymphoid leukemias.
    Takeuchi H; Kayano H; Hirose T
    Exp Hematol; 2000 May; 28(5):543-50. PubMed ID: 10812244
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Action of novel CD37 antibodies on chronic lymphocytic leukemia cells.
    Krause G; Patz M; Isaeva P; Wigger M; Baki I; Vondey V; Kerwien S; Kuckertz M; Brinker R; Claasen J; Frenzel LP; Wendtner CM; Heider KH; Hallek M
    Leukemia; 2012 Mar; 26(3):546-9. PubMed ID: 21886169
    [No Abstract]   [Full Text] [Related]  

  • 31. Tumor necrosis factor as marker for monocyte function in chronic myeloid leukemia.
    Chitnis VS; Parikh PM; Nadkarni JS; Kulkarni VC; Advani SH
    Cancer Invest; 1996; 14(3):231-3. PubMed ID: 8630684
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Optimized mitogen stimulation induces proliferation of neoplastic B cells in chronic lymphocytic leukemia: significance for cytogenetic analysis.The Tampere Chronic Lympocytic Leukemia group.
    Larramendy ML; Siitonen SM; Zhu Y; Hurme M; Vilpo L; Vilpo JA; Knuutila S
    Cytogenet Cell Genet; 1998; 82(3-4):215-21. PubMed ID: 9858820
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Highly similar genomic landscapes in monoclonal B-cell lymphocytosis and ultra-stable chronic lymphocytic leukemia with low frequency of driver mutations.
    Agathangelidis A; Ljungström V; Scarfò L; Fazi C; Gounari M; Pandzic T; Sutton LA; Stamatopoulos K; Tonon G; Rosenquist R; Ghia P
    Haematologica; 2018 May; 103(5):865-873. PubMed ID: 29449433
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CD1d is expressed on B-chronic lymphocytic leukemia cells and mediates alpha-galactosylceramide presentation to natural killer T lymphocytes.
    Fais F; Morabito F; Stelitano C; Callea V; Zanardi S; Scudeletti M; Varese P; Ciccone E; Grossi CE
    Int J Cancer; 2004 Apr; 109(3):402-11. PubMed ID: 14961579
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tumor necrosis factor receptor signaling is a driver of chronic lymphocytic leukemia that can be therapeutically targeted by the flavonoid wogonin.
    Dürr C; Hanna BS; Schulz A; Lucas F; Zucknick M; Benner A; Clear A; Ohl S; Öztürk S; Zenz T; Stilgenbauer S; Li-Weber M; Krammer PH; Gribben JG; Lichter P; Seiffert M
    Haematologica; 2018 Apr; 103(4):688-697. PubMed ID: 29326123
    [TBL] [Abstract][Full Text] [Related]  

  • 36. TACI expression and signaling in chronic lymphocytic leukemia.
    Mamara A; Germenis AE; Kompoti M; Palassopoulou M; Mandala E; Banti A; Giannakoulas N; Speletas M
    J Immunol Res; 2015; 2015():478753. PubMed ID: 25950010
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Simultaneous occurrence of chronic lymphocytic and chronic myeloid leukemia.
    Katović SK; Vasilj A; Maricević I; Carzavec D; Jurić SC
    Coll Antropol; 2010 Jun; 34(2):653-5. PubMed ID: 20698147
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Stereotyped B-cell receptors in chronic lymphocytic leukemia.
    Agathangelidis A; Vardi A; Baliakas P; Stamatopoulos K
    Leuk Lymphoma; 2014 Oct; 55(10):2252-61. PubMed ID: 24397617
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dysregulation of CD30+ T cells by leukemia impairs isotype switching in normal B cells.
    Cerutti A; Kim EC; Shah S; Schattner EJ; Zan H; Schaffer A; Casali P
    Nat Immunol; 2001 Feb; 2(2):150-6. PubMed ID: 11175813
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Chronic lymphocytic leukemia: studies on the effect of drug treatment on different lymphocytic subpopulations.
    Salsano F; Froland SS; Natvig JB; Mandelli F
    Scand J Immunol; 1976; 5(10):1185-90. PubMed ID: 1087747
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.